loader
Please Wait
Applying Filters...

Looking for 05433_FLUKA? Find Granulation used in 05433_FLUKA to address drug delivery challenges on PharmaCompass.

Menu
$ API Ref.Price (USD/KG) : 8Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2SPI Pharma

02 2Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

03 36BASF

04 3Corel Pharma Chem

05 2DFE Pharma

06 1Ingredion Pharma Solutions

07 6Kerry

08 5Microlex e.U

09 2Novo Excipients

10 2Pharmatrans-Sanaq

11 1Pluviaendo

12 1Prachin Chemical

13 1Roquette

14 4Sigachi Industries

15 3The Dow Chemical Company

16 2Ulanqab Kema New Material

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSPI Pharma has been solving formulation challenges using superior functional materials.

Grade : Oral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSPI Pharma has been solving formulation challenges using superior functional materials.

03

arrow
OTS 2025
Not Confirmed

04

arrow
OTS 2025
Not Confirmed
arrow
OTS 2025
Not Confirmed

Brand : KOLLIDON SR

Applications : For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.

Pharmacopoeia Ref : Ph. Eur., USP-NF, JP-JPE: 80 % Polyvinyl acetate and 19 % povidone, 0.8 % lauryl sulfate & 0.2 % silica (4:1)

Technical Specs : Not Available

Grade : Not Available

arrow
blank

06

arrow
OTS 2025
Not Confirmed